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Abstract 
Subchondral bone sclerosis is a well-recognised manifestation of osteoarthritis (OA). The 
osteocyte cell network is now considered to be central to the regulation of bone homeo-
stasis; however, it is not known whether the integrity of the osteocyte cell network is altered 
in OA patients. The aim of this study was to investigate OA osteocyte phenotypic changes and 
its potential role in OA subchondral bone pathogenesis. The morphological and phenotypic 
changes of osteocytes in OA samples were investigated by micro-CT, SEM, histology, im-
munohistochemistry, TRAP staining, apoptosis assay and real-time PCR studies. We 
demonstrated that in OA subchondral bone, the osteocyte morphology was altered showing 
rough and rounded cell body with fewer and disorganized dendrites compared with the os-
teocytes in control samples. OA osteocyte also showed dysregulated expression of osteocyte 
markers, apoptosis, and degradative enzymes, indicating that the phenotypical changes in OA 
osteocytes were accompanied with OA subchondral bone remodelling (increased osteoblast 
and osteoclast activity) and increased bone volume with altered mineral content. Significant 
alteration of osteocytes identified in OA samples indicates a potential regulatory role of 
osteocytes in subchondral bone remodelling and mineral metabolism during OA pathogene-
sis. 
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INTRODUCTION 
Osteoarthritis (OA) is the most common mus-
culo-skeletal disorder, yet the aetiology is still un-
known. Regardless of the aetiology the disease is 
progressive and is characterised by a series of pre-
dictable clinical and radiological changes. More than 
30 years ago, Radin et al suggested that an increase in 
stiffness of subchondral bone, rendering it less capa-
ble of attenuating and distributing load throughout 
the joint, increased stress in the overlying articular 
cartilage, leading to the deterioration in OA (1, 2). One 
of the earliest changes seen radiographically, often 
before any joint space narrowing is observed, is sub-
chondral bone sclerosis. This sclerosis is recognised as 
a radiographic sign of osteoarthritis but its signifi-
cance has been little explored. 
Subchondral bone is made up of a specialized 
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connective tissue formed by a mineralized matrix 
containing specific type I collagen, proteoglycans, and 
several growth factors, as well as bone specific cell 
types: osteoblasts, osteocytes, and osteoclasts. It has 
been reported that OA subchondral bone shows 
dysregulated osteoblast (3) and osteoclast phenotype 
(4) however, it is currently not known whether oste-
ocyte cells undergo phenotypic changes during OA 
progression.  
Osteocytes are terminally differentiated osteo-
blasts residing within the mineralized bone matrix 
and make up more than 90-95% of all bone cells in the 
adult skeleton. The osteocyte-canalicular cell network 
is now considered to play a central and mul-
ti-functional role in regulating skeletal homeostasis 
(5). The most accepted theory for osteocytic function 
places these cells as transducers of mechanical strains 
that are translated into biochemical signals affecting 
the communication among osteocytes and between 
osteocytes and osteoblasts or osteoclasts (6). This 
cascade of events may ultimately regulate bone re-
modelling and mineral metabolism (7). Since me-
chanical knee misalignment and altered joint geome-
try were known causes of OA (8), it is likely that os-
teocytes might undergo enormous changes given that 
their function is to act as transducers of mechanical 
strains. 
This study was designed to understand the 
pathophysiology of osteocyte network in OA patients 
by determining changes in osteocyte morphology, 
distribution, apoptosis, and evaluating the expression 
of osteocyte markers and matrix degradation en-
zymes. The phenotypic changes of osteocytes in OA 
patients were evident and these changes might be 
responsible for the active site-specific remodelling of 
subchondral bone, resulting in subchondral bone 
thickening and dysregulated mineral metabolism. 
MATERIALS AND METHODS 
Patients 
OA patients undergoing total knee replacement 
were recruited for this study after informed consent 
was given. This study was approved by The Queens-
land University of Technology and Prince Charles 
Hospital ethics committees. Patient variables i.e., 
height, weight and age were recorded and preopera-
tive radiographs of the knee, anteroposterially and 
laterally, were taken. The Subchondral bone was 
classified using scoring system set by The American 
College of Rheumatology (9). OA cartilage was classi-
fied according to the modified Mankin score (10). 
According to the previous studies (11), the patients 
were classified as OA (n=5) with a Mankin score 
greater than 5 and normal control (n=5) with a score 
less than 3.  
Micro-CT 
Morphological changes of subchondral bone in 
control vs. OA specimens were determined using Mi-
cro-CT. Tibial plate samples were scanned with micro 
CT (Scanco 40, Switzerland) with isotropic voxel size 
of 18 μm after tissues were fixed in 4% paraformal-
dehyde (PFA) in PBS as scanning medium. The x-ray 
tube voltage was 55 kV and the current was 145 μA, 
with a 0.5 mm aluminium filter. The exposure time 
was 1180 ms. The data set was segmented with an 
inbuilt software. In the medial and the lateral part of 
each tibia, a volume of interest (VOI) was selected 
with automatic contouring method. The circles were 
located in the middle of the load-bearing and 
non-load bearing sites of subchondral bone areas. 
Selected areas contained subchondral plate, but did 
not contain subchondral trabecular bone or 
growth-plate tissue. A total of 30 consecutive tomo-
graphic slices were analysed. The meaningful sub-
chondral bone plate measurements such as bone 
volume (mg HA/ccm) and BV/TV (%) were analysed 
using inbuilt software. Subchondral bone thickness 
was measured quantitatively using Axio Vision soft-
ware by converting number of pixels to micro meters.  
Scanning electron microscopy (SEM) analysis 
for osteocytes 
SEM and backscatter SEM was performed as 
described earlier (12). For resin-casted SEM, samples 
were dissected and fixed in 2.5% glutaraldehyde in 0.1 
M sodium cacodylate buffer containing 0.05% tannic 
acid. The tissue specimens were dehydrated in as-
cending concentrations of ethanol (from 70% to 100%), 
embedded in methyl methacrylate, and then surface 
polished using 1 μm and 0.3 μm Alpha Micropolish 
Alumina II (Buehler) in a soft-cloth rotating wheel. 
The bone surface was acid etched with 37% phos-
phoric acid for 2–10 seconds, followed by 5% sodium 
hypochlorite for 5 min. The samples were then coated 
with gold and palladium as described previously (13) 
and examined using an FEI/Philips XL30 
Field-Emission Environmental Scanning Electron Mi-
croscope. 
For back-scattered SEM (BSEM), the samples 
were fixed overnight in 2% paraformaldehyde and 2% 
glutaraldehyde buffered at pH 7.4 with 0.1 M sodium 
cacodylate. Samples were then rinsed three times (20 
min each time) in 0.1 M cacodylate buffer solution 
followed by secondary fixation (1 h) in a solution of 
1% osmium tetroxide in 0.1 M cacodylate buffer. The 
BSEM samples were then coated with carbon and 
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examined using an FEI/ Philips XL30 Field-Emission 
Environmental Scanning Electron Microscope 
Histology tissue preparation 
All samples containing any overlying cartilage 
and subchondral bone were dissected to an approxi-
mate depth of 1cm. All of the samples for histology 
and immunohistochemical analysis were washed in 
saline and immediately fixed in 4 % paraformalde-
hyde for 24 hours. The samples were washed in 
phosphate buffer solution (PBS) for one hour and then 
placed in 10% ethylene diamine tetraacetic acid 
(EDTA) for decalcification. The EDTA solution (PH 
7.0) was changed weekly for four weeks and decalci-
fication was confirmed by radiographic analysis. 
Tissue specimens were embedded in paraffin wax 
once the decalcification was complete. Tissue slices of 
5 µm thick were sectioned using microtome, placed on 
3-aminopropyltriethoxy-silane coated glass slides, 
air-dried and stored at 4 0C prior to analysis. Each 
specimen was H&E stained to visualize the general 
morphology.  
H&E staining 
Tissue slices were dewaxed in xylene and rehy-
drated in descending concentrations of ethanol (100% 
to 70%), sections were then stained with Mayers’s 
haemotoxylin for 1-2 minutes before washing with tap 
water for 5 minutes. The slides were dehydrated in 
ascending concentration of ethanol (70% to 100%) and 
stained with eosin for 15 seconds and cleared with 
xylene and mounted on DePeX mounting medium 
(BDH Laboratory Supplies, England). 
Immunohistochemistry 
Immunohistochemistry was carried out using an 
indirect immunoperoxidase method. Tissue slices 
were dewaxed in xylene and rehydrated. Endogenous 
peroxidases were blocked by incubation in 0.3% per-
oxide for 30 min followed by repeated washing in 
PBS. The sections were then incubated with protein-
ases K (DAKO Multilink, CA, USA) for 20 min for 
antigen retrival. Next, all sections were treated with 
0.1% bovine serum albumin (BSA) with 10% swine 
serum in PBS. Sections were then incubated with op-
timal dilution of primary antibody overnight at 4 0C. 
Optimum concentration of antibodies was deter-
mined by using a series of dilutions. After 24 hours, 
sections were incubated with a biotinylated 
swine-anti-mouse, rabbit, goat antibody (DAKO Mul-
tilink, CA, USA) for 15 min, and then incubated with 
horseradish perioxidase-conjugated avidin-biotin 
complex for 15 min. Antibody complexes were visu-
alized by the addition of a buffered diaminobenzidine 
(DAB) substrate for 3 min and the reaction was 
stopped by rinsing sections in PBS. Sections were 
counterstained with Mayer’s haematoxylin for 10 sec 
each, and rinsed with running tap water. Following 
this, dehydrated with ascending concentrations of 
ethanol solutions, cleared with xylene and mounted 
with coverslip using DePeX mounting medium. Con-
trols for the immunostaining procedures included 
conditions where the primary antibody and the sec-
ondary (anti-mouse IgG) antibodies were omitted. In 
addition, an irrelevant antibody (anti CD-15), which 
was not present in the test sections, was used as a 
control. A list of antibodies sources and dilutions used 
for this study are summarized in Table 1.  
 
Table 1: Details of antibodies and the working dilutions 
used in this study. 
Protein Dilution Source 
SOST 1:100 R & D systems 
DMP-1 1:1000 Gift from Prof Jian Feng 
MMP-9 1:150 Labvison, Fremont, CA 
ADAMTS4 1:100 Labvison, Fremont, CA 
MMP1 1:200 Labvison, Fremont, CA 
 
Resin embedding 
Undecalcified tissue samples were embedded in 
Poly-Methyl methacrylate (PMMA). Samples were 
dehydrated through a graded ethanol series and pro-
cessed through three changes of xylene then infil-
trated with Methyl methacrylate (MMA) and subse-
quently incubated with a mixture of MMA and poly-
ethylene glycol. To initiate the polymerisation pro-
cess, the catalyst Perkadox (0.3%) was added to 
MMA/PEG (3%) solution. Samples were fully cov-
ered with the MMA/PEG/Perkadox solution and 
incubated at 50ºC for 10 min. Specimens were put to 
rest until fully polymerised. Embedded samples were 
cut into 5 μm sections using an automated sledge mi-
crotome (Reichert-Jung, Polycut S), stretched with 
70% ethanol and collected onto gelatine coated mi-
croscope slides. Sections were overlaid with a plastic 
film and slides were clamped together prior to drying 
for 12 h at 60ºC. Sections were deplastified in xylene, 
rehydrated and stained using von Kossa staining 
procedures and Goldner staining using standard 
protocols.  
Distribution of osteocyte cell number and la-
cunae 
Subchondral bone plate was defined as starting 
from the calcified cartilage (CC) bone junction and 
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ending at the marrow space. Meaningful parameters 
to describe our area of interest were determined by 
measuring the thickness of the subchondral plate in 
all samples under 10 x magnification and calculating 
the average length (0.98mm) and calculating the av-
erage area (mm2). Average osteocyte nucleus (Avg 
OS.N) and average osteocyte empty lacunae (Avg 
OS.L) were counted per unit area, within the defined 
area of interest using AxioVision Rel 4.8 Software. The 
Avg OS.N and Avg OS. Lac between control and OA 
are represented in a bar graph.  
In situ cell death detection (apoptosis) using 
TUNEL 
Osteocyte apoptosis was assessed principally at 
single cell level, based on labelling of DNA strand 
breaks (Terminal deoxynucleotidyl transferase dUTP 
nick end labelling or TUNEL technology) using In Situ 
Cell Death Detection Kit, Fluorescein (Roche, Ger-
many) according to manufacturer’s protocol. Tissue 
sections were permeabilised for 30min at 370C with 
Proteinase K solution (Roche, Germany). As a positive 
control, sections were treated with DNase1 for 10 min 
at room temperature prior to labelling procedure was 
used to induce DNA strand breaks. The tunel reaction 
mixture / terminal transferace was omitted for the 
negative control. Subchondral bone plate was defined 
as starting from the calcified cartilage (CC) bone 
junction and ending at the marrow space. Meaningful 
parameters to describe our area of interest were de-
termined by measuring the thickness of the subchon-
dral plate in all samples under 10 x magnifications 
and calculating the average length (0.98mm) and cal-
culating the average area. TUNEL positive osteocyte 
was counted in 3 fields per section within the defined 
area of interest using AxioVision Rel 4.8 Software. The 
average TUNEL positive osteocyte between control 
and OA are represented in a bar graph. 
Quantitative real time polymerase reaction 
(qPCR)  
qPCR was performed to detect the gene expres-
sion differences in control and OA bone lysates. 
Briefly, for total RNA extraction, the fresh bone tis-
sues were obtained from OA patients (collected in 
RNAse later solution) and graded according to the 
disease severity. Small fragments of bone pieces were 
cut by using bone cutter and tissues were homoge-
nised using the bead beater for one minute. Total 
RNA was extracted using Trizol method and qPCR 
was performed as described previously (14, 15). The 
quality and integrity of the RNA extracted were con-
firmed on 1% wt/vol ethidium bromide-stained aga-
rose gels.  
Western blot  
Total tissue protein was harvested by lysing the 
subchondral bone in a lysis buffer containing 1 M Tris 
HCl (pH 8), 5 M NaCl, 20% Triton X-100, 0.5 M EDTA 
and a protease inhibitor cocktail (Roche, Dee Why, 
NSW, Australia). The cell lysate was clarified by cen-
trifugation and the protein concentration determined 
by a bicinchoninic acid protein assay (Sigma-Aldrich). 
10 g of protein was separated by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis on a 12% 
gel. The protein was transferred to a nitrocellulose 
membrane, and blocked in a Tris-Tween buffer con-
taining 5% non-fat milk. The membranes were incu-
bated with primary antibodies against ALP (1:1,000) 
and OCN (1:2,000) overnight at 4ºC. The membranes 
were washed three times in TBS-Tween buffer, and 
then incubated with an anti-rabbit secondary anti-
body at 1:2,000 dilutions for 1 hr. The protein bands 
were visualized using the ECL Plus™ Western Blot-
ting Detection Reagents (GE Healthcare, Rydalmere, 
NSW, and Australia) and exposed on X-ray film (Fu-
jifilm, Stafford, QLD, Australia). Immunoblot nega-
tives were analyzed by densitometry using Image J 
software. 
Tartrate resistant acid phosphatase (TRAP) 
staining of paraffin embedded samples  
 
To detect osteoclast activity, TRAP staining was 
performed as described previously by Erlebacher et al 
(16). Paraffin sections of 5 μm thickness were depar-
affinised in two changes of xylene (8 min each) and 
rehydrated (2 changes 95% ethanol, 2 min each; 1 
change 70% and 50% ethanol each 5 min, deionised 
water 5 min). After rehydration, samples were placed 
in 0.2 M Acetate Buffer (0.2 M sodium acetate and 50 
mM L(+) tartaric acid in ddH2O, pH 5.0) for 20 min at 
room temperature. Subsequently sections were incu-
bated with 0.5 mg/ml naphtol AS-MX phosphate 
(Sigma) and 1.1 mg/ml fast red TR salt (Sigma) in 0.2 
M acetate buffer for 1-4 h at 37ºC until osteoclasts 
appeared bright red. Samples were counterstained 
with Haematoxylin, air dried and mounted with 
ProLong® Gold (Invitrogen) mounting solution. 
Statistical analysis  
Paired Student’s t-test was used to determine 
any significance between control vs. OA subchondral 
bone, by counting the % positive staining cells in the 
field of view for immunohistochemistry, by counting 
the Avg OS.N and Avg OS.L (per unit area), and for 
distribution studies. P≤0.05 was considered signifi-
cant.  
Int. J. Biol. Sci. 2012, 8 
 
http://www.biolsci.org 
410 
RESULTS 
Patient demographics and specimen charac-
terization  
The mean age of all patients was 72 years (range 
63 – 79), mean weight was 93.4 kg (range 64-105) and 
mean height was 173 cm (range 162-185). H&E stain-
ing was performed to confirm the site specific changes 
in the samples. All control specimens showed normal 
appearing articular cartilage with underlying sub-
chondral bone. The outer (radial) layer of noncalcified 
cartilage (NC) was separated from the underlying 
calcified cartilage (CC) layer by the tidemark (TM). 
Immediately adjacent to the CC was the subchondral 
bone plate (SB). In contrast, OA specimens showed 
cartilage loss with a small region on the edge of the 
slide where there was some preservation of the deep 
and middle zone cartilage layers. The NC was much 
thinner and the CC was relatively thicker in OA sam-
ples when compared to the control specimens. 
Therefore, the distance between the TM and the SB 
was thicker than in the normal specimens. SB ad-
vancement in the OA specimens was seen in all the 
patients indicating extensive bone remodeling. Col-
lectively, these results show significant site-specific 
changes in OA patients. 
Altered gene expression, micro-architectural 
and mineral properties in OA subchondral 
bone 
A representative of the 3-D reconstruction of 
subchondral bone from micro-CT images (fig 1a, i-ii) 
showed significant changes in the microstructure of 
subchondral bone in OA patients. Compared with 
control, OA subchondral bone was significantly 
thicker and denser with a plate like structure. Quan-
titative micro-CT data revealed that OA specimens 
had a 20% increase in bone volume fraction compared 
to the control group (p = 0.049) (fig 1a, iii). Similarly, 
an increase in the subchondral bone thickness and 
mean density was observed in OA patients (fig 1a, 
iv-v). To further investigate these at the molecular 
level, it was noted that the mRNA (fig 1b, i-iii) and 
protein (fig 1b, iv) synthesis of alkaline phosphotase 
(ALP), osteopontin (OPN) and osteocalcin (OCN) 
were significantly higher in OA samples compared to 
patient matched controls. These results indicate ab-
normal site-specific OA bone phenotypic properties. 
 
Figure 1: Micro-architectural and mineral properties in OA subchondral bone: A representative 3-D reconstructions of tibial 
bone specimens of control and OA from micro-CT scans (a, i-ii) and quantitative results show OA subchondral bone plate has a higher 
bone volume fraction, mineral content and thickness compared to control specimens (a, iii-v) . Molecular marker changes: qRT-PCR was 
used to measure the gene expression levels of ALP, OPN and OCN. ALP and OPN showed a significant increase in OA bone (b,i-iii). At 
the protein level, a similar trend was observed using western bolt (b,iv). Tubulin was used as an internal loading control. Bars equals 
mean±SD, n=5, *p≤0.05. Goldner staining of control and OA samples (c, i-ii). Von kossa stained sections (c,iii-iv). Back scatter SEM 
(BS-SEM) images (c, v-vi). 
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Goldner staining showed that there were signif-
icantly increased un-mineralized areas (stained or-
ange) in OA subchondral bone compared with con-
trols (fig 1c, i-ii). This was further confirmed by Von 
kossa staining on the un-decalcified tissue samples, 
which showed that the mineral content distribution 
was significantly altered in OA subchondral bone, 
showing increased less mineralized areas compared 
with controls (Black staining shows the distribution of 
mineral content and white shows the distribution of 
un-mineralized areas) (fig 1c, iii-iv). Similarly, 
backscatter SEM images showed significantly disor-
ganized mineral distribution compared with the con-
trols where the white/grey areas show the distribu-
tion of mineral content and the black areas show the 
lack of mineral content (fig 1c, v-vi).  
Distorted osteocyte distribution and mor-
phology in OA samples  
A representative H&E staining of the subchon-
dral bone of OA and patient matched control shows 
the histological appearance of osteocyte morphology, 
number and distribution. Arrows represent osteocyte 
nucleus and arrow heads represent empty osteocyte 
lacunae (fig 2a, i-ii). Average osteocyte lacunae 
(Avg.OS.Lac) density was significantly increased in 
the OA patients compared to controls (P = 0.0041). 
However, no significant differences were observed 
with respect to Average osteocyte nucleus 
(Avg.OS.N) (P=0.0691) or viable osteocyte count (fig 
2a, iii-iv). We examined the morphology of OA oste-
ocytes using back scatter SEM (fig 2b, i-ii) and SEM 
(fig 2b, iii-vi) and it revealed that the osteocytes in 
OA samples were markedly deformed with a rough, 
lysed (fig 2b iv&vi) and rounded appearance (Fig 
2b, ii) with very few dendrites compared to spindle 
shaped (fig 2b, i), well organised and well con-
nected osteocytes (fig 2b, iii&v) in the control 
specimens. Furthermore, mineral distribution was 
disorganised, showing woven appearance in OA 
(fig 2b, ii) compared with well organised and con-
sistent mineral distribution in normal samples (fig 
2b, i). It was also noticed blood vessel invasion in 
OA subchondral bone (fig 2b, iv).  
 
 
Figure 2: Disrupted osteocyte morphology and dis-
tribution in OA patients: H&E staining of the subchondral 
bone of OA and patient matched control showing the histo-
logical appearance of osteocyte morphology, number and 
distribution. Arrows represent osteocyte nucleus and arrow 
heads represent osteocyte lacunae (a, i-ii). OA subchondral 
plate showed no significant increase in the Avg OS.N (P= 
0.0691) compared to control (a, iii). OA subchondral plate 
showed a significant increase in the Avg OS.Lac (P= 0.0041) 
compared to control (a, iv). Bars equal mean±SD, n=5, 
*p≤0.05.(b, i-ii) Back scatter image and (b, iii-vi) SEM images 
show clear morphological differences which include rough 
lysed and rounded appearance with fewer dendrites in OA 
osteocytes and blood vessel (arrows) invasion in OA samples 
(b, iv).  
 
Dysregulated osteocyte markers in OA os-
teocytes  
Osteocytes selectively express sclerostin 
(SOST), which is well characterised as negative 
regulator of bone formation. We performed a 
comparative immunohistochemical analysis of 
SOST expression in OA and patient matched con-
trol samples. When quantified by assessing the 
percentage fraction of SOST-positive osteocytes 
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among total osteocytes, major differences became 
evident. SOST expression was observed in more than 
half of the osteocytes in the control specimens but was 
significantly reduced in OA samples (P=0.001), indi-
cating a suppressed expression of this bone regulatory 
protein in OA (fig 3, a-b). In contrast to these findings 
the expression of Dentin Matrix Protein 1 (DMP1, 
regulator of bone mineralisation) staining was 
stronger in OA osteocytes and the percentage of 
DMP1 positive osteocytes were higher in OA com-
pared to control specimens (P=0.0002) (fig 3, d-e). The 
expression of DMP1 and SOST has been correlated to 
the ratio of bone volume to total volume (BV/TV) 
showing that increase in bone volume was correlated 
with the expression of increased DMP1 and decreased 
SOST (fig 3, c&f).  
 
 
Figure 3: Expression of osteocyte markers and the correlation to BV/TV: Immunohistochemical analysis shows a decrease in 
the average % positive stained osteocytes for SOST in OA patients compared to controls (P=0.001) (a-b). and an increase in the average 
% positive stained osteocytes for DMP1 in OA patients compared to controls (P=0.003) (d-e) Correlation studies reveals that the 
expression of SOST decreases with the increase in bone volume to total volume (BV/TV) (c) and the expression of DMP1 increases with 
increase in BV/TV f). 
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Increased apoptosis and TRAP positive stain-
ing in OA osteocyte  
The number of average TUNEL and TRAP posi-
tive osteocytes was significantly higher in OA osteo-
cytes compared to controls. In OA subchondral bone 
there were increased osteoclast activity showing 
TRAP positive (fig 4a, ii) compared to the control (fig 
4a, i). Interestingly, osteocytes in OA samples also 
showed positive staining of TRAP (fig 4a, iv) com-
pared with the controls (fig 4a, iii) , where osteocytes 
showed negative TRAP staining. A representative 
TUNEL stained section showed more number of os-
teocytes undergoing apoptosis in OA samples (fig 4b, 
ii)compared to controls (fig 4b, i). The average 
TUNEL positive osteocyte between control and OA 
are represented in a bar graph (fig 4b, iii).  
Dysregulated expression of degradative en-
zyme expression in OA osteocytes  
Matrix metalloproteinases (MMPs) are well rec-
ognized as mediators of matrix degradation, and their 
activity by virtue of the cleavage of matrix substrates 
are well known. We showed that the intensity of 
MMP-1. (fig 5, a-c), MMP-9 (fig 5, d-f), and 
ADAMTS4 (fig 5, g-i) signals were stronger and the 
percentage of positive osteocytes were significantly 
higher in OA samples compared to control patient 
specimens.  
 
Figure 4: Defective osteoclast / osteocyte TRAP 
expression and increased apoptosis (TUNEL posi-
tive) in OA osteocytes: A representative TRAP stained 
section shows an increased in the number of osteoclasts (a, 
i-ii). Increased TRAP positive osteocytes were observed in 
OA subchondral bone (a, iii-iv). A representative TUNEL 
stained section shows that more number of OA osteocytes 
are undergoing apoptosis compared to controls. Arrows 
represent TUNEL positive osteocytes and arrow heads 
represents live/nuclear stain (b, i-ii). b, iii is the bar graph 
showing increased TUNEL positive OA osteocytes. Bars 
equal mean±SD, n=5, *p≤0.05. 
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Figure 5: Dysregulated expression of degradative enzymes: Significant increase in the average percentage positive stained os-
teocytes in OA samples was observed with (a-c) MMP1 (p=0.001), (d-f) MMP9 (p=0.0026), (g-i) ADAMTs4 (p=0.0042) compared controls. 
Bars equal mean±SD, (n=5), *p≤0.05. 
 
 
DISCUSSION 
Subchondral bone sclerosis is a major 
patho-physiological manifestation of OA, and it is still 
unknown if it precedes cartilage breakdown in this 
disease. Regardless of whether bone sclerosis is the 
initiating event, it perturbs the overlying cartilage in 
OA patients; therefore, preventing subchondral bone 
sclerosis may contribute to improving the comfort 
and mobility of OA patients (17). It is now evident 
that subchondral bone cells such as osteoblasts and 
osteoclasts undergo significant changes in OA (18). 
However, recent studies emphasise the importance of 
osteocyte in maintaining the bone homeostasis. Stud-
ies have demonstrated that osteocytes regulate the 
behaviour of osteoblasts and osteoclasts by com-
municating through gap junctions (19). With this ev-
idence, we hypothesised that osteocyte function may 
be hampered in OA leading to OA osteocyte pheno-
type and this could play an important pathological 
role in subchondral bone sclerosis. Our findings sug-
gest that the various functional properties of osteo-
cytes appear to be changed in patients with OA.  
In OA, the increase in bone volume, density, and 
stiffening of subchondral bone has been reported and 
the possible reason for this change might be due to 
bone remodelling in response to repetitive mi-
cro-damage/fracture as a result of an imbalance in 
mechanical loading of the joint (20). In this study we 
identified that OA subchondral bone showed an in-
creased bone volume and the bone mineral content 
was significantly altered. We further demonstrated 
that these subchondral bone changes in OA were 
correlated with the expression of osteocyte markers, 
which showed decreased SOST and increased DMP1 
expression in OA samples. Osteocyte expression of 
SOST is a delayed event and it is produced only by 
mature osteocytes after they become embedded in 
matrix that has been mineralized. From then on, ma-
ture osteocytes appear to express SOST whether they 
are located in osteons or bone. SOST knockout mice 
have a progressive high bone mass phenotype (21, 22). 
The precise physiological role of SOST in osteocytes is 
not yet fully understood, but numerous studies indi-
cate that loss of SOST expression enhances osteogen-
esis (23). Currently, it is thought that SOST passes 
through the osteocytic canalicular network to the 
bone surface where it inhibits osteoblastic canonical 
Wnt/beta-catenin signaling, which is implicated in 
bone mass regulation (24-26). Therefore, decreased 
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SOST expression in OA osteocytes may be responsible 
for the increased bone volume in OA subchondral 
bone.  
In contrast to the expression of SOST, increased 
expression of DMP1 can induce impairment in min-
eralization (27, 28) with poorly organized mineral and 
an apparent delay in the transition from osteoblasts to 
osteocytes. In this study it was found that OA sub-
chondral bone showed significant dysregulation in 
mineral metabolism. This may be due to the increased 
expression of DMP1 in OA osteocytes. DMP-1 is a 
secretory protein and an osteocyte marker essential 
for normal postnatal chondrogenesis and subsequent 
osteogenesis (29). In vivo studies have shown that 
DMP1 actively participates in bone homeostasis and 
mineralization and mechanical loading stimulates 
DMP1 expression in osteocytes (30-32). It can be as-
sumed that increased expression of DMP1 in OA os-
teocytes may disrupt the normal mineralization pro-
cess in OA subchondral bone, resulting in increased 
osteoid volume and irregular mineralization of OA 
subchondral bone. The surprising finding of de-
creased SOST and increased DMP1 expression in OA 
osteocytes may be indicative of elevated bone turno-
ver resulting in increased subchondral bone volume 
in OA samples - a characteristic feature of OA. Indeed, 
we demonstrated that bone turnover markers (ALP, 
OPN, OCN, MMPs, TRAP) were significantly upreg-
ulated in OA samples compared with controls, indi-
cating an underlying potential mechanism leading to 
OA subchondral bone changes.   
Osteocytes and their connections are highly dy-
namic, as observed by their constant contraction and 
expansion of osteocyte bodies within the lacunae and 
by the extension and retraction of dendrites thus 
adapting mechanical load (33). This may imply that 
the shape of osteocytes is determined by external 
loading and imbalanced mechanical stimulation can 
lead to morphological changes. Our SEM results 
showed that OA subchondral bone osteocytes (OA 
osteocyte phenotype) were more rounded, rough and 
were not aligned in any particular direction, however, 
the patient matched control samples showed spindle 
shaped and uniformly aligned osteocytes (Normal 
osteocyte phenotype). These results indicate that an 
irregular morphology of osteocytes increases OA 
predilection and this might alter the ability of bone to 
sense mechanical stimuli leading to significant 
changes in the structure and mineral density. It could 
be interpreted as a phenomenon where the signals 
passing through osteoblasts and osteoclasts could be 
hampered. Indeed, increased osteogenic activities 
(ALP, OPN and OCN expression) and increased os-
teoclastic activity (TRAP statining) were noted in OA 
subchondral bone. 
An adequate number of osteocytes are essential 
to remove bone microdamage, and the osteocyte den-
sity correlates with the quality of bone (34). In this 
study we found that average osteocyte lacunae 
(Avg.OS.Lac) number was significantly higher in OA 
bone compared to normal’s, however no significant 
differences were observed with respect to total num-
ber of osteocyte nucleus count. This could be ex-
plained by the increased osteocyte apoptosis, showing 
TUNEL positive osteocytes in OA samples.  
Our results clearly showed the rough, lysed and 
rounded appearance of the lacunae and canaliculi of 
osteocytes in OA samples. To adapt to mechanical 
stimuli, osteocytes modulate their mechanical envi-
ronment by regulating their attachment to the matrix 
(35). MMPs are well recognized as mediators of ma-
trix degradation, and their activity by virtue of the 
cleavage of matrix substrates are well known. As ex-
pected, we found that MMP-1, MMP-9 and 
ADAMTS4 were all significantly increased in OA 
compared to control giving a possible indication to 
assume that the osteocyte morphology will corrode its 
coupling to the matrix by producing digestive en-
zymes such as MMPs. The function of osteocyte 
through death and the expression of MMPs in bone 
remodelling and joint disease has been emphasised by 
various independent researchers (36-38). Role of os-
teocytes in the regulation of bone resorption has been 
largely unknown. TRAP staining has been regarded 
as one of the reliable markers of osteoclasts. Few 
studies have shown the expression of TRAP in oste-
ocytes close to the bone resorbing surface and its rela-
tion to MMPs (39-41). With this in view, TRAP posi-
tive and MMPs positive osteocytes may control the 
direction of osteoclastic resorption in OA subchondral 
bone. However, these results need further investiga-
tion to understand the cellular interactions between 
TRAP positive osteocytes and osteoclasts during bone 
resorption. Another limitation of the study is the rela-
tively small sample size of human samples. Even 
though the osteocyte changes are obvious as evi-
denced in the five OA samples, validation studies 
with larger sample sizes need to be performed.  
CONCLUSION 
Our study provides evidence that OA osteocyte 
phenotype has distinctive changes both phenotypi-
cally and morphologically. We conclude that the OA 
osteocyte phonotypic changes participate in OA sub-
chondral bone pathogenesis. These characteristic OA 
changes could be caused by the activa-
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tion/deactivation of osteocyte signalling molecules in 
the OA microenvironment.  
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